CHO Cell Line Development Service

Sartorius CHO Cell Line Development Technology License empowers biopharmaceutical companies to establish proven cell line development capabilities in-house. This comprehensive solution combines over 15 years of expertise with cutting-edge technology to accelerate therapeutic protein development from DNA to research cell bank.

The technology package includes all essential components: 4Cell® SmartCHO media and feeds, proprietary host cell line, plasmid vectors, and standardized protocols covering gene synthesis, vector cloning, transfection, and pool generation. Two licensing options address different development needs - the Research Package enables feasibility and manufacturability assessment from DNA to pool, while the Commercial Package extends capabilities to research cell bank generation.

Implementation flexibility represents a key advantage, requiring only basic cell culture equipment like flow boxes, incubators, and shakers. While electroporators, cell counters, and Octet® systems enhance efficiency, the technology adapts to existing laboratory setups. Protocols can be customized to match specific infrastructure and workflow requirements.

Comprehensive support ensures successful technology transfer and implementation. Each license includes personalized documentation, proof of concept studies, troubleshooting assistance, and technical support options including remote guidance and on-site visits. This support structure minimizes implementation risks and accelerates time to productive operations.

The technology leverages Sartorius' proven track record with over 300 completed cell line development projects and 80+ molecules currently in clinical stages. Seven molecules developed using this technology have achieved market approval, demonstrating regulatory acceptance and commercial viability.

For organizations seeking to build internal cell line development capabilities while maintaining control over intellectual property and timelines, this technology license provides access to industry-leading methods and materials. The solution enables faster decision-making, reduced external dependencies, and enhanced project confidentiality while benefiting from established, validated processes.